ESC 365 - Exploring thromboembolic risk and progress towards defining the role of anticoagulation in SCAF

Open Access

Exploring thromboembolic risk and progress towards defining the role of anticoagulation in SCAF

Session: Exploring new frontiers to anticoagulate in atrial fibrillation (AF): update on AF burden and subclinical AF

Topic: Oral Anticoagulation

Speaker: Professor J. Healey (Hamilton, CA)

Sponsored by BMS/Pfizer

Event: EHRA 2023

Congress Presentation

Add to my library

About the speaker

Professor Jeff Healey

Population Health Research Institute, Hamilton (Canada)

20 presentations

1 follower

3 more presentations in this session

Welcome and introductions

Speaker: Professor J. Camm (London, GB)

Understanding AF burden and its impact on patient outcomes

Speaker: Doctor E. Svennberg (Stockholm, SE)

Panel discussion and audience Q&A

Speaker: Professor J. Camm (London, GB)

Access the full session

Exploring new frontiers to anticoagulate in atrial fibrillation (AF): update on AF burden and subclinical AF

Speakers: Professor J. Healey, Professor J. Camm, Doctor E. Svennberg, Professor J. Camm

About the event

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources